
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 1 29-34, Copyright © 1991 by American Association for Cancer Research
ARTICLES |
SS Devesa, GL Shaw and WJ Blot
Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892.
Using data from five registries covering 7% of the U.S. population, we investigated lung carcinoma incidence trends from 1969-86 by histological type, sex, race, age, calendar time period, and cohort year of birth. Among white men, squamous cell carcinoma was the most frequent histological type, but by the mid-1980s the age-adjusted rates were decreasing while rates of adenocarcinoma and small (oat) cell carcinoma continued to rise. Among white women, adenocarcinoma was the most frequent type, followed by small cell carcinoma, with rates of all histological types rising over the entire study period. Similar time trends were seen among blacks. Rates for squamous cell carcinoma among both sexes and adenocarcinoma among men, however, were considerably higher for blacks than whites, whereas no racial disparity was seen for small cell carcinomas. Rates for each histological type were higher among men than women, although male-female sex ratios diminished over time. Age-specific rates varied considerably by cohort year of birth; incidence of squamous cell carcinoma among men increased steadily among those born from the late 1800s to the first quarter of this century before declining among those born thereafter. Cohort peaks were also reached, although about 10 to 20 years later, for small cell carcinoma and adenocarcinoma, suggesting an eventual reduction in incidence in these histological types as well. For each type, the peak incidence occurred earlier for men than women. These differing incidence patterns add to the evidence that the mechanisms of lung carcinogenesis may vary by histological type.
This article has been cited by other articles:
![]() |
J. C. Ho, M. Chan-Yeung, S. P. Ho, J. C. Mak, M. S. Ip, G. C. Ooi, M. P. Wong, K. W. Tsang, and W. K. Lam Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma Eur. Respir. J., February 1, 2007; 29(2): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gray The consequences of the unregulated cigarette. Tob. Control, October 1, 2006; 15(5): 405 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Larsen, M. L. Colosimo, I. A. Yang, R. Bowman, P. V. Zimmerman, and K. M. Fong CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung Carcinogenesis, March 1, 2006; 27(3): 525 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman Influence of Type of Cigarette on Peripheral versus Central Lung Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tokumo, S. Toyooka, K. Kiura, H. Shigematsu, K. Tomii, M. Aoe, K. Ichimura, T. Tsuda, M. Yano, K. Tsukuda, et al. The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non-Small Cell Lung Cancers Clin. Cancer Res., February 1, 2005; 11(3): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, S. Song, D. L. Ashley, and C. H. Watson Assessment of tobacco-specific nitrosamines in the tobacco and mainstream smoke of Bidi cigarettes Carcinogenesis, February 1, 2004; 25(2): 283 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reck, J. von Pawel, H.-N. Macha, E. Kaukel, K.-M. Deppermann, R. Bonnet, K. Ulm, S. Hessler, and U. Gatzemeier Randomized Phase III Trial of Paclitaxel, Etoposide, and Carboplatin Versus Carboplatin, Etoposide, and Vincristine in Patients With Small-Cell Lung Cancer J Natl Cancer Inst, August 6, 2003; 95(15): 1118 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Olson, P. Yang, K. Schmitz, R. A. Vierkant, J. R. Cerhan, and T. A. Sellers Differential Association of Body Mass Index and Fat Distribution with Three Major Histologic Types of Lung Cancer: Evidence from a Cohort of Older Women Am. J. Epidemiol., October 1, 2002; 156(7): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, D. P. Miller, W. Zhou, S. W. Thurston, R. Fan, L.-L. Xu, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani Differential Association of the Codon 72 p53 and GSTM1 Polymorphisms on Histological Subtype of Non-Small Cell Lung Carcinoma Cancer Res., December 1, 2001; 61(24): 8718 - 8722. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ramnath, F. J. Hernandez, D.-F. Tan, J. A. Huberman, N. Natarajan, A. F. Beck, A. Hyland, I. T. Todorov, J. S.J. Brooks, and G. Bepler MCM2 Is an Independent Predictor of Survival in Patients With Non-Small-Cell Lung Cancer J. Clin. Oncol., November 15, 2001; 19(22): 4259 - 4266. [Abstract] [Full Text] |
||||
![]() |
W. Zhou, S. W. Thurston, G. Liu, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani The Interaction between Microsomal Epoxide Hydrolase Polymorphisms and Cumulative Cigarette Smoking in Different Histological Subtypes of Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 461 - 466. [Abstract] [Full Text] |
||||
![]() |
N. Gray Reflections on the saga of tar content: why did we measure the wrong thing? Tob. Control, March 1, 2000; 9(1): 90 - 94. [Full Text] [PDF] |
||||
![]() |
G. B.J. Smith, A. Castonguay, P. J. Donnelly, K. R. Reid, D. Petsikas, and T. E. Massey Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells Carcinogenesis, September 1, 1999; 20(9): 1809 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Licker, J. Robert, and A. Spiliopoulos Time trend in the surgical management of patients with lung carcinoma Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 433 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Nugent, M. T. Edney, P. G. Hammerness, B. J. Dain, L. H. Maurer, and J. R. Rigas Non-Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment Ann. Thorac. Surg., January 1, 1997; 63(1): 193 - 197. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |